Alembic Pharmaceuticals has received an approval to raise up to Rs 1,000 crore through a qualified institutions placement (QIP). The board, at its meeting, has accorded its approval to raise up to Rs 1,000 crore through a QIP issue of equity shares.
Alembic Pharmaceuticals, a vertically integrated research and development pharmaceutical company, has been at the forefront of Healthcare since 1907.